Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
113.27
+0.51 (+0.45%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
AskSlim Market Week - Friday, Jan. 14
January 14, 2022
Technical and cycle analysis, and market commentary.
Via
Talk Markets
FDA Clears Abbott's Latest EnSite Heart Mapping Platform
January 12, 2022
Abbott Laboratories (NYSE: ABT) has scored clearance from the FDA for its latest 3D cardiac mapping platform, designed to help physicians target abnormal heart...
Via
Benzinga
Price Over Earnings Overview: Abbott Laboratories
January 11, 2022
In the current session, Abbott Laboratories Inc. (NYSE:ABT) is trading at $135.78, after a 0.4% gain. Over the past month, the stock increased by 2.13%, and in the...
Via
Benzinga
3 Top Stock Trades for the Week of Jan. 10, 2022
January 10, 2022
Sellers continue to push their advantage making it necessary to play defense to win. Here are three top stock trades for the new week.
Via
InvestorPlace
Wednesday Is Your Last Chance To Buy Abbott Laboratories Before The Dividend Payout
January 10, 2022
Wednesday marks the last chance for investors to receive the next dividend payout from Abbott Laboratories. What's Happening (N...
Via
Benzinga
This Company's Cardiac Monitor Has Caught the Eye of Johnson & Johnson and Stanford
January 07, 2022
Future Cardia’s device This post contains sponsored advertising content. The content that follows is for informational purposes only and not intended to be investing advice...
Via
Benzinga
Expert Ratings For Abbott Laboratories
December 10, 2021
Within the last quarter, Abbott Laboratories (NYSE:ABT) has observed the follo...
Via
Benzinga
How Digital Health Firms Like Apple, Alphabet And Garmin Are Innovating Far Beyond Your Wrist
January 06, 2022
Fitness trackers on display at CES 2022 are blazing a path toward a digital health future.
Via
Investor's Business Daily
Walmart And Kroger Jack Up Prices On COVID At-Home Tests After White House Agreement Not Extended
January 05, 2022
Walmart Inc. (NYSE: WMT) and The Kroger Company (NYSE: KR) have jacked up the price of the BinaxNOW rapid COVID-19 tests after a fixed-price sales deal with the Biden...
Via
Benzinga
6 Stocks Taking Center Stage At CES 2022, Including For The First Time A Healthcare Company
January 03, 2022
The Consumer Electronics Show (CES) in Las Vegas will be one of the most followed events of 2022 to kick off the year in the technology space. The show may come in...
Via
Benzinga
Best Stocks for 2022: Why AbbVie Looks Like High Dividend Growth Stock
December 30, 2021
A solid year and an excellent third-quarter report from AbbVie has ABBV stock look like it is one of the best stocks to buy for 2022.
Via
InvestorPlace
CES 2022: Electric Vehicles, Digital Health, Metaverse In Focus
December 30, 2021
CES will spotlight EVs, digital health, the metaverse and other hot technologies, Jan. 5-8.
Via
Investor's Business Daily
7 Dividend Increases Expected In January 2022
December 30, 2021
How many dividend increases are you going to receive this month? How many stocks on this list do you own? Are you ready to crush it in 2022?
Via
Talk Markets
Price Over Earnings Overview: Abbott Laboratories
December 29, 2021
In the current session, Abbott Laboratories Inc. (NYSE:ABT) is trading at $140.53, after a 0.1% increase. Over the past month, the stock increased by 10.83%, and in...
Via
Benzinga
5 Stocks Insiders Are Selling
December 29, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
Could This Company's Device Be What the Cardiology Market Has Been Yearning For? Company Touts it as a Lifesaver
December 28, 2021
Photo by Towfiqu Barbhuiya on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Watch for Continued Gains in Shares of Abbott Laboratories
December 27, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded at a new 12-month high today of $142.60. This new high was reached on below-average trading volume as 814,000 shares traded hands...
Via
Benzinga
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
December 21, 2021
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to...
Via
Benzinga
Abbott Laboratories: Debt Overview
December 21, 2021
Shares of Abbott Laboratories (NYSE:ABT) moved higher by 8.53% in the past three months. Before we understand the importance of debt, let us look at how much debt Abbott...
Via
Benzinga
This Cardiac Device Could Possibly Be the Game Changer That Saves Millions of Lives
December 21, 2021
Photo by Jesse Orrico on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Abbott Laboratories: The Winning Streak Continues
December 17, 2021
Abbott Laboratories (NYSE: ABT) traded at a new 12-month high today of $139.11. Approximately 4 million shares have changed hands today, as compared to an average 30-day volume of...
Via
Benzinga
$1000 Invested In This Stock Over The Last 5 Years, Would Be Worth This Much
December 16, 2021
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 13.08% on an annualized basis. Buying $1,000.00 In ABT: 5 years ago, an investor could have...
Via
Benzinga
Johnson & Johnson: What Should Investors Do Following The Consumer Health Spinoff?
December 15, 2021
A sizeable change in direction for one of the country’s oldest companies was probably a shock to many shareholders.
Via
Talk Markets
3 Coronavirus Stocks To Buy In December
December 11, 2021
Moderna is the leading company in the development of messenger RNA-based medicines and vaccines to treat infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune...
Via
Talk Markets
Exposures
COVID-19
3 Healthcare Stocks for Long-Term Dividend Growth
December 10, 2021
Dividend investors face a variety of choices. We like healthcare stocks for many reasons, such as long-term earnings growth.
Via
InvestorPlace
Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
December 09, 2021
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 12.02% on an annualized basis. Buying $100.00 In ABT: 5 years ago, an investor could have...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
This Biotech CEO Is Trying To Cure His Son's Rare Disease
December 09, 2021
Few questions stump Tim Walbert. But the Horizon Therapeutics CEO is still working to answer one of them from his son.
Via
Investor's Business Daily
Watch for Continued Gains in Shares of Abbott Laboratories
December 07, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.